#2905 CLINICAL OUTCOMES OF ORAL ANTICOAGULATION AND NO ANTICOAGULATION AMONG HEMODIALYSIS PATIENTS WITH ATRIAL FIBRILLATION
نویسندگان
چکیده
Abstract Background and Aims The delicate balance of risk versus benefit oral anticoagulation in the general population is well established but decision to use these agents end-stage renal disease (ESRD) remains complex difficult owing paucity clinical trials lack substantial evidence literature for its safe effective haemodialysis population. This study aims determine difference outcomes between no therapy among ESRD patients on maintenance with atrial fibrillation. Method a prospective, single-center, observational conducted Perpetual Succour Hospital that included all at least 3 months Out 188 identified patients, only 69 were grouped according how cardiac dysrhythmia was approached either or anticoagulation. Basic demographic information obtained as aetiology ESRD, CHA2DS2-VASc Score HAS-BLED Score. Lastly, prospectively followed period 12 then assessed new onset thromboembolic events, hemorrhagic calciphylaxis all-cause mortality. Results At enrolment, 59 (85.5%) have 10 (14.5%) already receiving Ischemic strokes more prevalent who anticoagulant (80%, p <0.0001). Patient differ significantly terms intracranial hemorrhage (30%, p= 0.0004) gastrointestinal bleeding (50%, <0.00001) which noted In relation over-all mortality, acute myocardial infarction, peripheral arterial occlusive calciphylaxis, there significant two groups. Conclusion suggests did not prevent ischemic fibrillation associated increased haemorrhage bleeding. There
منابع مشابه
Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation
BACKGROUND AND OBJECTIVES Anticoagulation with vitamin K antagonists (VKAs) such as warfarin provides effective stroke prophylaxis in patients with atrial fibrillation (AF). We conducted a large multicenter survey of Korean patients with AF to determine trends in VKA use. SUBJECTS AND METHODS Eligible patients were adults with AF that had been prescribed VKAs. Medical records from a total of ...
متن کاملCardioversion Of Atrial Fibrillation And Oral Anticoagulation.
The risk of thromboembolic events is a major concern in cardioversion of atrial fibrillation. The vast majority of these events occur in the first week following cardioversion. Processes promoting thrombus formation occur early and thrombus may appear in the left atrium within 48 hours of atrial fibrillation. The risk of thromboembolic events also increases with the presence of stroke risk fact...
متن کاملPrevalence of oral anticoagulation in atrial fibrillation
OBJECTIVES Atrial fibrillation is the most common sustained arrhythmia and is associated with poor outcomes, including stroke. The ability of anticoagulation therapy to reduce the risk of stroke has been well established; however, the prevalence of anticoagulation therapy use in the Public Health System is unknown. The aim of this study is to evaluate both the prevalence of anticoagulation ther...
متن کاملclinical implications of recent trials on anticoagulation in patients with atrial fibrillation
متن کامل
Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide. In 2008, the estimated agestandardized AF prevalence in China was 0.65%, suggesting that at least 4 million adults had AF, and it was predicted that 5.2 million men and 3.1 million women aged >60 years will be affected by AF in China by 2050. AF increases the risk of stroke, and AF-related stroke is more fatal a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2023
ISSN: ['1460-2385', '0931-0509']
DOI: https://doi.org/10.1093/ndt/gfad063d_2905